Obesity and the outcome of young breast cancer patients in the UK: The POSH study

Annals of Oncology

Volumn 26, Issue 1, 2015, Pages 101-112

  Copson, Ellen R ^a   Cutress, R I ^a   Maishman, T ^a   Eccles, B K ^a   Gerty, S ^a   Stanton, L ^a   Altman, D G ^b   Durcan, L ^a   Wong, C ^a   Simmonds, P D ^a   Jones, L ^c   Eccles, D M ^a   Simmonds, Peter ^d   Pharoah, Paul ^d   Jones, Louise ^d   Eeles, Ros ^d   Evans, Gareth ^d   Thompson, Alistair ^d   Hodgson, Shirley ^d   Hamed, Hisham ^d   Bishop, Tim ^d   Warren, Ruth ^d   Gilbert, Fiona ^d   Lakhani, Sunil ^d   Hanby, Andrew ^d   more..

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d NONE

Author keywords

Breast cancer; Obesity; Prognosis

Indexed keywords

ANTHRACYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TAXANE DERIVATIVE; TRASTUZUMAB; ERBB2 PROTEIN, HUMAN; PROSTAGLANDIN RECEPTOR;

ADJUVANT THERAPY; ADULT; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; BREAST CANCER; BREAST SURGERY; CANCER GRADING; CANCER THERAPY; CLINICAL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE INTERVAL; DISTANT DISEASE FREE INTERVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OBESITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POST HOC ANALYSIS; PROSPECTIVE STUDY; TREATMENT DURATION; TUMOR VOLUME; UNDERWEIGHT; UNITED KINGDOM; UNIVARIATE ANALYSIS; ADOLESCENT; BREAST TUMOR; DISEASE FREE SURVIVAL; METABOLISM; MORTALITY; PATHOLOGY; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; BODY MASS INDEX; BREAST NEOPLASMS; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; GREAT BRITAIN; HUMANS; OBESITY; PROSPECTIVE STUDIES; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROSTAGLANDIN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84922546987     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdu509     Document Type: Article

References (26)

1. Wiseman M. The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Proc Nutr Soc 2008; 67: 253-256.
2. Cheraghi Z, Poorolajal J, Hashem T et al. Effect of body mass index on breast cancer during premenopausal and postmenopausal periods: a meta-analysis. PLoS One 2012; 7: e51446.
3. Renehan AG, Brennan BM. Acromegaly, growth hormone and cancer risk. Best Pract Res Clin Endocrinol Metab 2008; 22: 639-657.
4. Chan DSM, Viera AR, Aune D et al. Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Ann Oncol 2014; 25: 1901-1914.
5. Niraula S, Ocana A, Ennis M, Goodwin PJ. Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysis. Breast Cancer Res Treat 2012; 134: 769-781.
6. Majed B, Moreau T, Senouci K et al. Is obesity an independent prognosis factor in woman breast cancer? Breast Cancer Res Treat 2008; 111: 329-342.
7. Ewertz M, Jensen MB, Gunnarsdottir KA et al. Effect of obesity on prognosis after early-stage breast cancer. J Clin Oncol 2011; 29: 25-31.
8. Griggs JJ, Mangu PB, Anderson H et al. Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 2012; 30: 1553-1561.
9. Wang YC, McPherson K, Marsh T et al. Health and economic burden of the projected obesity trends in the USA and the UK. Lancet 2011; 378: 815-825.
10. European Commission. Eurostat: European Health Survey, 2008. http://epp.eurostat.ec.europa.eu/statistics_explained/index.php/Overweight_and_obesity-BMI_statistics (January 2014, date last accessed).
11. Flegal K, Carroll M, Kit B et al. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012; 307: 491-497.
12. Eccles D, Gerty S, Simmonds P et al. Prospective study of Outcomes in Sporadic versus Hereditary breast cancer (POSH): study protocol. BMC Cancer 2007; 7: 160.
13. Copson E, Eccles B, Maishman T et al. Prospective observational study of breast cancer treatment outcomes for UK women aged 18-40 years at diagnosis: the POSH study. J Natl Cancer Inst 2013; 105: 978-988.
14. Geneva WHO. Physical status; the use and interpretation of anthropmetry. Report of a WHO expert committee. (Technical report series, No. 854), 1995.
15. von Elm E, Altman DG, Egger M et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370: 1453-1457.
16. Azzato EM, Greenberg D, Shah M et al. Prevalent cases in observational studies of cancer survival: do they bias hazard ratio estimates? Br J Cancer 2009; 100: 1806-1811.
17. Copson E, Maishman T, Gerty S et al. Ethnicity and outcome of young breast cancer patients in the United Kingdom: the POSH study. Br J Cancer 2014; 110: 230-241.
18. Khandekar MJ, Cohen P, Spiegelman BM. Molecular mechanisms of cancer development in obesity. Nat Rev Cancer 2011; 11: 886-895.
19. Ligibel JA, Strickler HD. Obesity and its impact on breast cancer: tumor incidence, recurrence, survival, and possible interventions. Am Soc Clin Oncol Educ Book 2013; 33: 52-59.
20. de Azambuja E, McCaskill-Stevens W, Francis P et al. The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial. Breast Cancer Res Treat 2010; 119: 145-153.
21. Gouerant S, Leheurteur M, Chaker M et al. A higher body mass index and fat mass are factors predictive of docetaxel dose intensity. Anticancer Res 2013; 33: 5655-5662.
22. Pan H, Gray RG. Early Breast Cancer Trialists' Collaborative Group; Effect of obesity in premenopausal ER+ early breast cancer: EBCTCG data on 80,000 patients in 70 trials. J Clin Oncol 2014; 32: 5s. (suppl; abstr 503).
23. Sparano JA, Wang M, Zhao F et al. Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer. Cancer 2012; 118: 5937-5946.
24. Pfeiler G, Konigsberg R, Fesl C et al. Impact of body mass index on the efficacy of endocrine therapy in premenopausal patients with breast cancer: an analysis of the prospective ABCSG-12 trial. J Clin Oncol 2011; 29: 2653-2659.
25. Sinicrope FA, Dannenberg AJ. Obesity and breast cancer prognosis: weight of the evidence. J Clin Oncol 2011; 29: 4-7.
26. Schmitz KH, Neuhouser ML, Agurs-Collins T et al. Impact of obesity on cancer survivorship and the potential relevance of race and ethnicity. J Natl Cancer Inst 2013; 105: 1344-1354.